Literature DB >> 11089521

Novel cyclic adenosine 3',5'-monophosphate (cAMP) response element modulator theta isoforms expressed by two newly identified cAMP-responsive promoters active in the testis.

P B Daniel1, L Rohrbach, J F Habener.   

Abstract

cAMP signaling contributes to the control of the developmental progression of germ cells during the spermatogenic cycle. Genes regulated by cAMP include those encoding transcription factors such as the cAMP-responsive element modulator (CREM). The disruption of CREM gene expression in crem null mice results in arrest of spermatogenesis and infertility. The transcriptional control of the CREM gene is attributed to two promoters, P1 and P2. The P1 promoter constitutively activates the synthesis of messenger RNAs encoding activator (tau) and repressor (alpha) forms of CREM, whereas the cAMP-responsive P2 promoter activates the formation of messenger RNAs encoding the inducible cAMP early repressor. Here we report the identification of two additional promoters in the CREM gene, P3 and P4, that in the rat testis encode two novel transcriptional activator CREM isoforms, termed CREM theta1 and CREM theta2, respectively. Notably, the P3 and P4 promoters are activated by cAMP-dependent protein kinase, thereby providing cAMP-regulated transcription of CREM activators in addition to the established cAMP-regulated inducible cAMP early repressor. Analysis ex vivo of CREM gene expression in temporally staged segments of the seminiferous tubule during the spermatogenic cycle shows that the activities of the P1, P3, and P4 promoters are independently regulated. Our identification of the cAMP-activated P3 and P4 promoters that direct expression of the novel theta1 and theta2 activator isoforms of CREM brings further insight into the complex expression of the CREM gene during germ cell development and may have implications in understanding the control of fertility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089521     DOI: 10.1210/endo.141.11.7758

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.

Authors:  Lizi Wu; Jingxuan Liu; Ping Gao; Makoto Nakamura; Yang Cao; Huangxuan Shen; James D Griffin
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

2.  A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.

Authors:  Thomas Rauen; Konrad Benedyk; Yuang-Taung Juang; Claus Kerkhoff; Vasileios C Kyttaris; Johannes Roth; George C Tsokos; Klaus Tenbrock
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

3.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

4.  Osteopenia in transgenic mice with osteoblast-targeted expression of the inducible cAMP early repressor.

Authors:  Taranpreet K Chandhoke; Yu-Feng Huang; Fei Liu; Gloria A Gronowicz; Douglas J Adams; John R Harrison; Barbara E Kream
Journal:  Bone       Date:  2008-03-29       Impact factor: 4.398

5.  Novel insights into the downstream pathways and targets controlled by transcription factors CREM in the testis.

Authors:  Rok Kosir; Peter Juvan; Martina Perse; Tomaz Budefeld; Gregor Majdic; Martina Fink; Paolo Sassone-Corsi; Damjana Rozman
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.